DR. ERIC S NYLEN, MD
Osteopathic Medicine at Irving St, Washington, DC

License number

DC MD18173

Personal information

See more information about ERIC S NYLEN at radaris.com

Name

Address

Phone

Eric S Nylen, age 70

5109 Dudley Ct, Bethesda, MD 20814

(301) 897-8714

Eric S Nylen

2150 Pa Ave Nw, Washington, DC 20090

(202) 994-3695

Eric S Nylen

2150 Pa, Washington, DC 20090

(202) 994-3695

Eric S Nylen

2150 Pennsylvania Ave, Washington, DC 20037

(202) 994-3695
(703) 994-3695

Eric S Nylen

2150 Penn St, Washington, DC 20001

(202) 994-3695

Professional information

See more information about ERIC S NYLEN at trustoria.com

Eric Sixtus Nylen, Washington DC

Specialties:

Internal Medicine, Endocrinology, Diabetes & Metabolism, Endocrinology and Metabolism

Work:

Washington DC Va Medical Center
50 Irving St Nw, Washington, DC 20422

Education:

Georgetown University (1982)

Dr. Eric S Nylen, Washington DC - MD (Doctor of Medicine)

Specialties:

Endocrinology, Diabetes & Metabolism

Address:

George Washington University Medical END
2150 Pennsylvania Ave NW SUITE 3416, Washington 20037
(202) 741-3333 (Phone), (202) 741-2490 (Fax)

Certifications:

Diabetes, Metabolism & Endocrinology, 2002, Internal Medicine, 1985

Awards:

Healthgrades Honor Roll

Languages:

English

Hospitals:

George Washington University Medical END
2150 Pennsylvania Ave NW SUITE 3416, Washington 20037
The George Washington University Hospital
900 23Rd St North #West, Washington 20037

Education:

Medical School
Georgetown University School Of Medicine
Graduated: 1982
Geo Washington University Hospital
Vet Affairs Med Center

Method And Compositions For Preventing And Treating The Systemic Inflammatory Response Syndrome Including Sepsis

US Patent:

5993811, Nov 30, 1999

Filed:

Feb 3, 1997

Appl. No.:

8/794740

Inventors:

Kenneth L. Becker - Washington DC
Jon C. White - Chevy Chase MD
Eric S. Nylen - Bethesda MD
Richard H. Snider - Upper Marlboro MD

Assignee:

Biology Associates, LLC - Bethesda MD

International Classification:

A61K 39395

US Classification:

4241301

Abstract:

Administration of an antibody reactive to procalcitonin and/or its components is effective for the treatment and/or prevention of systemic inflammatory response syndrome (SIRS) and sepsis.